Skip to main content
ALLIANCE PHARMA PLC logo

ALLIANCE PHARMA PLC — Investor Relations & Filings

Ticker · APH ISIN · GB0031030819 LEI · 213800RYIWZA4Q5WPZ13 IL Wholesale and retail trade
Open in API
Filings indexed 492 across all filing types
Latest filing 2021-03-02 Major Shareholding Noti…
Country GB United Kingdom
Listing IL APH

About ALLIANCE PHARMA PLC

https://www.alliancepharmaceuticals.com/

Alliance Pharma PLC is an international specialty pharmaceutical company with a primary focus on consumer healthcare. The company's business model is centered on the acquisition, licensing, and marketing of a portfolio of consumer health products and prescription medicines. It operates globally, investing in its key brands to empower consumers to improve their health and wellbeing. A core part of its strategy is the ongoing development to become a high-performing consumer healthcare company.

Recent filings

Filing Released Lang Actions
Notification of Major Holdings
Major Shareholding Notification Classification · 99% confidence The document is clearly identified by the header 'RNS Number : 9092Q' and contains the standard boilerplate text indicating it is provided by RNS, the news service of the London Stock Exchange. The content itself is a 'TR-1: Standard form for notification of major holdings,' which details changes in voting rights held by a shareholder (MVM Partners LLP) crossing a threshold. This type of mandatory disclosure regarding significant changes in share ownership falls under the category of Major Shareholding Notification (MRQ). Although it is an RNS filing, MRQ is a more specific and accurate classification than the general 'RNS' fallback.
2021-03-02 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is identified by the RNS Number (7468Q) and explicitly states it is a notification in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. The content details the 'Total Voting Rights' as of a specific date (26 February 2021), which is a mandatory disclosure related to share capital and voting power. This type of mandatory, periodic disclosure regarding share structure, often triggered by changes or as a routine update, fits best under the general regulatory announcement category, as it is not a specific financial report (10-K, IR), management change (MANG), or dividend notice (DIV). Since it is a formal regulatory announcement distributed via RNS, and it doesn't fit the highly specific categories like DIRS (Director's Dealing) or MRQ (Major Shareholding Notification), the most appropriate classification is Regulatory Filings (RNS). The document length is short (3572 chars), but it is a direct regulatory filing, not an announcement *about* another report.
2021-03-01 English
Notification of Preliminary Results
Report Publication Announcement Classification · 99% confidence The document is a formal announcement released via RNS (RNS Number: 4889P) on February 18, 2021. The title explicitly states it is a "Notification of Preliminary Results, Analyst Conference Call and Webcast." It informs the market that the full results for the 12 months ended 31 December 2020 will be announced on March 23, 2021, and provides details about the subsequent analyst call and webcast. Since the document itself is not the full financial report (like a 10-K or IR) but rather an announcement about the *timing* and *availability* of future reports and related events (conference call/webcast), it fits the definition of a Report Publication Announcement (RPA). It is short and serves to inform stakeholders about the upcoming release of the actual results.
2021-02-18 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official notification released via RNS (RNS Number : 5296N) on 01 February 2021. It explicitly states it is making a notification in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1 regarding the 'Total Voting Rights' as of a specific date (29 January 2021). This type of announcement, which details the total number of shares and voting rights, is a standard regulatory disclosure. While it is a regulatory filing, it does not fit the specific definitions for DIRS (Director's Dealing), MRQ (Major Shareholding Notification), or SHA (Share Issue/Capital Change). Since it is a mandatory regulatory disclosure that doesn't fit a more specific category, the most appropriate classification is the general Regulatory Filings category (RNS). The document length is short (3577 chars) and it is a direct announcement, not an announcement *of* a larger report.
2021-02-01 English
Full Year Trading Update
Earnings Release Classification · 99% confidence The document is titled 'Full Year Trading Update' and provides unaudited trading figures for the year ended 31 December 2020, ahead of the audited results announcement on March 23, 2021. It contains key financial metrics (revenues, profit before tax expectation, free cash flow, net debt) and strategic updates (acquisition of Biogix/Amberen). This content structure—a preliminary summary of annual performance released before the full 10-K or audited results—is characteristic of an Earnings Release (ER). Although it covers the full year, it is explicitly an 'update' and not the comprehensive 'Annual Report' (10-K) or the 'Interim Report' (IR) which covers shorter periods. The RNS Number and the closing boilerplate confirm it is a regulatory announcement, but the content itself is the earnings summary. FY 2020
2021-01-20 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a short regulatory announcement identified by the 'RNS Number' and the reference to the 'UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1'. The content explicitly states the 'Total Voting Rights' as of a specific date (31 December 2020) and provides this figure for shareholders to use as a denominator for regulatory calculations. This type of notification regarding the total number of shares and voting rights is a standard regulatory disclosure. Since it is not a full annual report (10-K), an earnings release (ER), or a specific management/board change, and it is a direct regulatory filing disseminated via RNS, it fits best under the general 'Regulatory Filings' category (RNS) as a specific type of mandatory disclosure, although it is closely related to share capital changes. Given the options, RNS is the most appropriate general regulatory filing code for this type of mandatory disclosure that isn't covered by a more specific code like DIRS or SHA.
2021-01-04 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.